Home/Recalls/FDA-D-0507-2026
FDA DrugsClass II

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL...

Published: May 6, 2026Recall ID: D-0507-2026Category: drugsCountry: US

Reason for Recall / Hazard

cGMP deviations.

Product Description & Identification

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.

Affected Products

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.

Additional Source Details

FieldValue
CityHouston
StateTX
Event id98694
Address 19265 Kirby Dr
Code info120925302312764, Exp Date 04/09/2026, 123125302312879 Exp Date, 05/05/2026, 123125302312880, Exp Date 05/05/2026, 010226302310003, Exp Date 05/06/2026, 010626302310007, Exp Date 05/08/2026, 010626302310008, Exp Date 05/08/2026 020426302310243, Exp Date 06/06/2026.
Postal code77054-2520
Report date20260506
Product typeDrugs
Product quantity4975 syringes
Reason for recallcGMP deviations.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260401
Initial firm notificationLetter
Center classification date20260428

Overview

  • Recalling FirmWells Pharma of Houston LLC
  • StatusOngoing
  • Risk LevelClass II
  • DistributionU.S. Nationwide.
Official Agency Alert